CureApp is a digital health startup
CureApp is a digital health startup.The firm is one of the leading players in the medical app vertical under the theme of “app exhibits therapeutic effects against diseases” and launched a nicotine addiction treatment app in February 2015, which was jointly developed with Division of Pulmonary Medicine, Keio University’s School of Medicine. It is currently conducting clinical trials in many locations.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 12, 2021 | Series D | ¥2.10B | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SIIF | — | Series D |
Healthcare Innovation | — | Series D |